262 related articles for article (PubMed ID: 30617729)
21. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
[TBL] [Abstract][Full Text] [Related]
22. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
[TBL] [Abstract][Full Text] [Related]
23. The utility of 18F-fluorocholine PET/CT in the imaging of parathyroid adenomas.
Mazurek A; Dziuk M; Witkowska-Patena E; Chudzinski W; Piszczek S; Gizewska A; Saracyn M
Endokrynol Pol; 2022; 73(1):43-48. PubMed ID: 35119087
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of technetium-99m-sestamibi uptake and washout in parathyroid scintigraphy supports dual mechanisms of lesion conspicuity.
Robin P; Klein R; Gardner J; Ziebarth B; Bazarjani S; Razavi S; Zuckier LS; Zeng W
Nucl Med Commun; 2019 May; 40(5):469-476. PubMed ID: 30762617
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of ⁹⁹mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with ⁹⁹mTc-sestamibi scintigraphy, SPECT, US and CT.
Kim YI; Jung YH; Hwang KT; Lee HY
Ann Nucl Med; 2012 Dec; 26(10):804-10. PubMed ID: 22875576
[TBL] [Abstract][Full Text] [Related]
26. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Neck Ultrasonography, Dual Phase
Abhishek B; Wakankar R; Dharmashaktu Y; Damle NA; Kumar P; Bal C; Tripathi M; Kandasamy D; Khadgawat R; Agarwal S; Vuthaluru S; Chumber S
Indian J Nucl Med; 2023; 38(3):208-217. PubMed ID: 38046978
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
29. 11C-methionine PET/CT in 99mTc-sestamibi-negative hyperparathyroidism in patients with renal failure on chronic haemodialysis.
Rubello D; Fanti S; Nanni C; Farsad M; Castellucci P; Boschi S; Franchi R; Mariani G; Fig LM; Gross MD
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):453-9. PubMed ID: 16435115
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT.
Eslamy HK; Ziessman HA
Radiographics; 2008; 28(5):1461-76. PubMed ID: 18794320
[TBL] [Abstract][Full Text] [Related]
31. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
32. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism.
Neumann DR; Esselstyn CB; Maclntyre WJ; Go RT; Obuchowski NA; Chen EQ; Licata AA
J Nucl Med; 1996 Nov; 37(11):1809-15. PubMed ID: 8917180
[TBL] [Abstract][Full Text] [Related]
33. Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.
Thulé P; Thakore K; Vansant J; McGarity W; Weber C; Phillips LS
J Clin Endocrinol Metab; 1994 Jan; 78(1):77-82. PubMed ID: 8288719
[TBL] [Abstract][Full Text] [Related]
34. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?
Weber T; Gottstein M; Schwenzer S; Beer A; Luster M
World J Surg; 2017 Apr; 41(4):980-985. PubMed ID: 27834016
[TBL] [Abstract][Full Text] [Related]
35.
Gass JM; Wicke C; Mona C; Strobel K; Müller W; Metzger J; Suter-Widmer I; Henzen C; Fischli S
Endocrine; 2022 Feb; 75(2):593-600. PubMed ID: 34561784
[TBL] [Abstract][Full Text] [Related]
36. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
Amadou C; Bera G; Ezziane M; Chami L; Delbot T; Rouxel A; Leban M; Herve G; Menegaux F; Leenhardt L; Kas A; Trésallet C; Ghander C; Lussey-Lepoutre C
World J Surg; 2019 May; 43(5):1232-1242. PubMed ID: 30659347
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hyperplasia detected by F-18-Choline PET/CT, negative on Tc-99m-MIBI SPECT/CT and F-18-Deoxyglucose PET/CT scans.
Nocuń A; Kędra M; Stefaniak B; Chrapko B
Nucl Med Rev Cent East Eur; 2017; 20(1):60-61. PubMed ID: 28218350
[No Abstract] [Full Text] [Related]
38.
Gauthé M; Dierick-Gallet A; Delbot T; Bricaire L; Bertherat J; North MO; Cochand-Priollet B; Bouchard P; Talbot JN; Groussin L; Gaujoux S
World J Surg; 2020 Nov; 44(11):3761-3769. PubMed ID: 32681321
[TBL] [Abstract][Full Text] [Related]
39. Dual-Time-Point
Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179
[No Abstract] [Full Text] [Related]
40. Usefulness of combination of high-resolution ultrasonography and dual-phase dual-isotope iodine 123/technetium Tc 99m sestamibi scintigraphy for the preoperative localization of hyperplastic parathyroid glands in renal hyperparathyroidism.
Périé S; Fessi H; Tassart M; Younsi N; Poli I; St Guily JL; Talbot JN
Am J Kidney Dis; 2005 Feb; 45(2):344-52. PubMed ID: 15685513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
